Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055365 · ClinicalTrials.gov registry record · NA
Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02055365 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 10 participants.
The verdict
NCT02055365, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Vaccines have been responsible for preventing millions of deaths and extending the average human lifespan. Effective vaccines stimulate the cells of the immune system to activate genes and associated functions that bring about protective immunity.This study aims to define cellular functions and genes important for the hepatitis B (HBV) vaccine immune response in healthy individuals. The investigators hypothesize that many genes associated with innate and adaptive immune functions are important for an effective HBV vaccine response.
Interventions
- BIOLOGICAL Hepatitis B Vaccine (Recombinant)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-02-18 |
| Est. Completion | 2015-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02055365
The ClinicalTrials.gov registry entry for NCT02055365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hepatitis B Vaccine (Recombinant) is the first listed.
NCT02055365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02055365 about?
NCT02055365 is a clinical study titled "Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers". Vaccines have been responsible for preventing millions of deaths and extending the average human lifespan. Effective vaccines stimulate the cells of the immune system to activate genes and associated functions that bring about protective immunity.This study aims to define cellular functions and gene...
What is the current status of trial NCT02055365?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-02-18. Estimated completion is 2015-01-06.
What interventions are being tested in trial NCT02055365?
The interventions under investigation include: Hepatitis B Vaccine (Recombinant) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02055365?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.